| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/06/2002 | EP1177029A2 High throughput crystal form screening workstation and method of use |
| 02/06/2002 | EP1176871A1 Novel beta-secretase and modulation of beta-secretase activity |
| 02/06/2002 | EP1176868A1 Method and apparatus for selectively classifying poultry eggs |
| 02/06/2002 | EP1105457B1 Card for counting and characterising micro-organisms |
| 02/06/2002 | EP1088096A4 Methods of screening compounds for bioactivity in organized tissue |
| 02/06/2002 | EP0941478B1 Assay method for peptide specific t-cells |
| 02/06/2002 | EP0885392B1 Process for differential diagnosis of various states of alzheimer's disease |
| 02/06/2002 | EP0871871A4 Improvements in ionic reservoir through application of an electrical potential |
| 02/06/2002 | EP0838027A4 Detection of small analytes |
| 02/06/2002 | EP0832105A4 Immunogenic peptides of prostate specific antigen |
| 02/06/2002 | EP0824688B1 Sensor assembly for controlling the ventilation of indoor spaces |
| 02/06/2002 | EP0789844B1 The use of a bmp protein receptor complex for screening bone metabolism actives and cells co-transfected with a type ii bmp receptor and a type i bmp receptor |
| 02/06/2002 | EP0730739B1 Process for coating surfaces with biological molecules and other receptor molecules |
| 02/06/2002 | EP0667961B1 Detection of anti-hpa antibodies |
| 02/06/2002 | EP0556281B1 A diagnostic assay for lyme disease |
| 02/06/2002 | CN2476023Y Hepatitis B surface antigen and a-fetoprotein double linking colloidal gold immune chromatography test paper slip |
| 02/06/2002 | CN1334924A Method of detecting presence of analyte in biological sample |
| 02/06/2002 | CN1334923A Whole cell selection utilizing azlactone-functional supports |
| 02/06/2002 | CN1334922A Assay to detect binding partner |
| 02/06/2002 | CN1334921A PGT and apoptosis |
| 02/06/2002 | CN1334879A Sequencing method using magnifying tags |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334463A Method for identifying cell specific target structure |
| 02/06/2002 | CN1334460A Biological sensor with porous chromatograph diaphragm |
| 02/06/2002 | CN1334343A Antibody for suppressing tumor growth, its derivative and its application |
| 02/05/2002 | US6345115 Digital imaging system for assays in well plates, gels and blots |
| 02/05/2002 | US6344872 System for transporting and imaging a textile material |
| 02/05/2002 | US6344653 Multi-photon laser microscopy |
| 02/05/2002 | US6344552 Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides |
| 02/05/2002 | US6344550 A dna molecule; diagnosing, monitoring and therapy of breast cancer |
| 02/05/2002 | US6344546 A receptor protein with a cytoplasmic domain having protein kinase activity, a kinase insert, a transmembrane domain and an extracellular domain having three immunoglobulin-like repeats; for drug screening |
| 02/05/2002 | US6344545 Method for preventing HIV-1 infection of CD4+ cells |
| 02/05/2002 | US6344544 Semaphorin-specific antibodies |
| 02/05/2002 | US6344542 A polypeptides involved in signal transduction; therapy and diagnosis of cancers, diabetes, obesity, anorexia, asthma, parkinson's disease, heart disease, strokes, allergies, schizophrenia, huntington's disease and tourett's syndrome |
| 02/05/2002 | US6344475 Cystic fibrosis |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344360 Detection of analytes by fluorescent lanthanide metal chelate complexes containing substituted ligands |
| 02/05/2002 | US6344358 Administering somatostatin releasing agent to treat brain, psychological and nervous system disorders such as schizophrenia, amnesia, bipolar disorder, alzheimer*s disease and parkinson*s disease |
| 02/05/2002 | US6344340 Viability assay for sporocyst-forming protozoa |
| 02/05/2002 | US6344339 Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR) |
| 02/05/2002 | US6344338 Obtaining a sample from a non-transgenic plant and isolating the endotoxin by incubating the sample in an extraction buffer having a ph range from 9.5 to 12.5, then react the endotoxin with antibodies and determine the degree of binding |
| 02/05/2002 | US6344337 Antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid |
| 02/05/2002 | US6344336 A detection method containing a fluid pathway and inputs for a sample and a reagent with a detectable marker,transporting the sample to a detection region through a barrier that prevents a product-reagent complex from passing |
| 02/05/2002 | US6344335 A sensitized liposome containing guaiac for detecting antigens or antibodies in blood sample |
| 02/05/2002 | US6344334 Detection of lead drug ligands such as proteins, nucleic acids or saccharides |
| 02/05/2002 | US6344333 Apparatus for immunological detection of preferential antigen, antibody or hapten |
| 02/05/2002 | US6344332 Methods for the rapid detection of actively respiring microorganisms |
| 02/05/2002 | US6344331 Water immiscible solvent based binding systems |
| 02/05/2002 | US6344330 Pharmacophore recombination for the identification of small molecule drug lead compounds |
| 02/05/2002 | US6344326 Microfluidic method for nucleic acid purification and processing |
| 02/05/2002 | US6344322 Subtle mitochondrial mutations as tumor markers |
| 02/05/2002 | US6344321 Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
| 02/05/2002 | US6344318 A selex method determining three dimensional structure of nucleic acid ligands by identifying a ligand to a specific target and modifying the nucleotides with a monomer to allow the ligand to mimic the structure and bind the target |
| 02/05/2002 | US6344314 Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 02/05/2002 | US6344271 Materials and products using nanostructured non-stoichiometric substances |
| 02/05/2002 | US6344203 Mimicking peptides in cancer therapy |
| 02/05/2002 | US6344181 Decreased endogenous nitric oxide activation |
| 02/05/2002 | US6343516 Multiphase flow sampling using an autotraversing sample probe |
| 02/05/2002 | US6343508 Method for representing properties of elongated textile test specimens |
| 02/05/2002 | US6343507 Method to improve the quality of a formation fluid sample |
| 02/05/2002 | US6343501 System and method for determining the process viscosity of a fluid in a film metering device |
| 02/05/2002 | CA2147484C Glucose test data acquisition and management system |
| 02/05/2002 | CA2116066C Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays |
| 02/05/2002 | CA2098113C Substances of polypeptide nature useful in human therapy |
| 02/05/2002 | CA2078006C Multichromophore fluorescent probes |
| 02/05/2002 | CA2070408C Enzyme assay and assay kit to measure cellular activation |
| 02/05/2002 | CA2068326C Fluorinated poly(naphthyl ethers) |
| 02/05/2002 | CA2039322C Automatic immunological measuring system |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/03/2002 | CA2340783A1 Ampk-related serine/threonine kinase, designated snark |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002009125A1 Spherical, magnetic sio2 particles with an adjustable particle and pore size and an adjustable magnetic content, method for producing them and use of sio2 particles of this type |
| 01/31/2002 | WO2002009012A2 Accessibility correction factors for electronic models of cytochrome p450 metabolism |
| 01/31/2002 | WO2002008965A2 Method for determining spatial distances in polymers |
| 01/31/2002 | WO2002008949A2 Methods and systems for evaluating a matching between measured data and standards |
| 01/31/2002 | WO2002008858A2 A method for ab initio determination of macromolecular crystallographic phases using bessel function |
| 01/31/2002 | WO2002008800A2 Coupling elements for surface plasmon resonance sensors |
| 01/31/2002 | WO2002008767A2 Methods and kits for sequencing polypeptides |
| 01/31/2002 | WO2002008766A1 Probe for analyzing protein-protein interaction and method of analyzing protein-protein interactions with the use of the same |
| 01/31/2002 | WO2002008765A2 Basal cell markers in breast cancer and uses thereof |
| 01/31/2002 | WO2002008764A1 Detection of abnormalities leading to cervical malignancy |
| 01/31/2002 | WO2002008763A2 Immunosensor |
| 01/31/2002 | WO2002008762A1 Apparatus and method for evanescent light fluoroassays |
| 01/31/2002 | WO2002008761A1 Improved blocking chemistries for nylon membrane |
| 01/31/2002 | WO2002008760A1 Method of identifying cancer markers and uses therefor in the diagnosis of cancer |
| 01/31/2002 | WO2002008759A1 Method for diagnosing thyroid conditions and for monitoring thyroxine therapy |
| 01/31/2002 | WO2002008758A1 Waveguide sensors optimized for discrimination against non-specific binding |
| 01/31/2002 | WO2002008757A1 Method for immuno-detection of epitopes |
| 01/31/2002 | WO2002008755A2 Identifying antigen clusters for monitoring a global state of an immune system |
| 01/31/2002 | WO2002008754A1 Spatially resolved enzyme-linked assay |
| 01/31/2002 | WO2002008753A2 Device for measuring analyte concentration in a fluid |
| 01/31/2002 | WO2002008752A1 Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms |
| 01/31/2002 | WO2002008751A2 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 01/31/2002 | WO2002008750A1 Test member |
| 01/31/2002 | WO2002008749A1 Method and apparatus for assessing or predicting characteristics of wood or other wooden materials |
| 01/31/2002 | WO2002008748A2 Ion channel assay methods |
| 01/31/2002 | WO2002008744A2 Method and devices for capillary electrophoresis with a norbornene based surface coating |